Euromedis Groupe SA
PAR:ALEMG

Watchlist Manager
Euromedis Groupe SA Logo
Euromedis Groupe SA
PAR:ALEMG
Watchlist
Price: 4.7 EUR -0.84%
Market Cap: €13.1m

Wall Street
Price Targets

ALEMG Price Targets Summary
Euromedis Groupe SA

There are no price targets for ALEMG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Euromedis Groupe SA Competitors:
Price Targets
XO
Exotic Food PCL
94% Upside
CAMT
Camtek Ltd
19% Upside
PHUN
Phunware Inc
274% Upside

Revenue
Forecast

-8% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-44%
Average Miss
-8% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-44%
Average Miss

For the last 8 years the compound annual growth rate for Euromedis Groupe SA's revenue is -8%. The projected CAGR for the next 2 years is 9%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALEMG's stock price target?
Not Available

ALEMG doesn't have any price targets made by Wall Street professionals.

What is Euromedis Groupe SA's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Euromedis Groupe SA's revenue is -8%. The projected CAGR for the next 2 years is 9%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett